期刊文献+

^(18)F-FDG PET/CT原发灶代谢参数对非小细胞肺癌隐匿性淋巴结转移的预测价值 被引量:17

Value of ^(18)F-FDG PET/CT metabolic parameters of primary lesions for predicting occult lymph node metastasis in non-small cell lung cancer
原文传递
导出
摘要 目的探讨基于^(18)F-脱氧葡萄糖(FDG)PET/CT肿瘤原发灶代谢参数对非小细胞肺癌(NSCLC)隐匿性淋巴结转移(OLM)的预测价值。方法回顾性分析2013年1月至2018年12月于苏州大学附属第三医院行^(18)F-FDG PET/CT检查并于术前诊断为临床N0期(cN0)的183例患者[男72例,女111例,年龄(61.5±8.4)岁],所有患者于检查后3周内于本院行原发灶切除术及系统性淋巴结清扫术,依据术后有无淋巴结转移分为OLM阳性(OLM+)组及OLM阴性(OLM-)组。分析获得^(18)F-FDG PET/CT原发灶相关参数:原发灶最大径(Dmax)、原发灶位置、形态学特征、原发灶最大标准摄取值(SUVmax)、平均标准摄取值(SUVmean)、肿瘤代谢体积(MTV)、病灶糖酵解总量(TLG)、原发灶SUVmax-肝SUVmean比值(TLRmax)、原发灶TLG-肝SUVmean比值(TLRTLG)。运用Mann-Whitney U检验、χ2检验对各参数进行组间比较,采用logistic回归分析OLM的独立危险因素,采用受试者工作特征(ROC)曲线分析评估不同参数的诊断效能。结果183例患者中,25例(13.7%,25/183)存在OLM,共46枚淋巴结转移(N1淋巴结15枚,N2淋巴结31枚)。OLM+组原发灶Dmax[2.9(2.3,3.7)与2.3(1.7,2.8)cm]、分叶征[76.0%(19/25)与37.3%(59/158)]、原发灶SUVmax[11.1(7.9,17.7)与4.7(2.3,9.2)]、TLG[41.5(10.2,91.1)与15.6(6.5,23.8)ml]、TLRmax[4.7(3.5,7.6)与2.1(0.9,4.0)]、TLRTLG[18.1(5.0,44.3)与6.1(3.0,11.4)ml]均高于OLM-组(z值:-4.709~-3.247,χ2=13.190,均P<0.05)。多因素logistic回归分析显示TLRmax[比值比(OR)=15.145,95%CI:3.381~67.830,P<0.001]和Dmax(OR=3.220,95%CI:1.192~8.701,P=0.021)是OLM的独立危险因素。TLRmax预测OLM ROC曲线下面积(AUC)最大(0.794),其阈值为3.12时诊断OLM的灵敏度、特异性、准确性、阳性预测值和阴性预测值分别为92.0%(23/25)、63.3%(100/158)、67.2%(123/183)、28.4%(23/81)和98.0%(100/102)。结论^(18)F-FDG PET/CT原发灶代谢参数TLRmax是NSCLC患者OLM的独立危险因素,其可灵敏预测NSCLC患者的OLM。 Objective To investigate the predictive value of ^(18)F-fluorodeoxyglucose(FDG)PET/CT metabolic parameters for occult lymph node metastasis(OLM)in non-small cell lung cancer(NSCLC).Methods A total of 183 patients(72 males,111 females;age(61.5±8.4)years)who underwent ^(18)F-FDG PET/CT and preoperatively diagnosed with clinical N0 stage(cN0)in Third Affiliated Hospital of Soochow University from January 2013 to December 2018 were retrospectively enrolled.All patients underwent anatomical pulmonary resection with systematic lymph node dissections within 3 weeks after ^(18)F-FDG PET/CT examinations.According to the presence or absence of lymph node metastasis,patients were divided into OLM positive(OLM+)group and OLM negative(OLM-)group.Parameters of primary lesions,such as the maximum diameter(Dmax),tumor sites,morphological features,maximum standardized uptake value(SUVmax),mean standardized uptake value(SUVmean),metabolic total volume(MTV),total lesion glycolysis(TLG),tumor SUVmax to liver SUVmean(TLRmax),tumor TLG to liver SUVmean(TLRTLG)were analyzed.Mann-Whitney U test andχ2 test were used to compare the parameters between groups.Multivariable logistic regression was used to analyze the independent risk factors for OLM.Receiver operating characteristic(ROC)curve analysis was used to evaluate the diagnostic value of different parameters.Results Among 183 patients,25(13.7%,25/183)of them were diagnosed as OLM.In OLM+group,46 lymph nodes were pathologically positive for metastasis,including 15 N1 disease and 31 N2 disease.Dmax(2.9(2.3,3.7)vs 2.3(1.7,2.8)cm),lobulation((76.0%(19/25)vs 37.3%(59/158)),SUVmax(11.1(7.9,17.7)vs 4.7(2.3,9.2)),TLG(41.5(10.2,91.1)vs 15.6(6.5,23.8)ml),TLRmax(4.7(3.5,7.6)vs 2.1(0.9,4.0))and TLRTLG(18.1(5.0,44.3)vs 6.1(3.0,11.4)ml)of the primary lesions in OLM+group were significantly higher than those in OLM-group(z values:from-4.709 to-3.247,χ2=13.190,all P<0.05).Multivariable logistic regression analysis showed that TLRmax(odds ratio(OR)=15.145,95%CI:3.381-67.830,P<0.001)and Dmax(OR=3.220,95%CI:1.192-8.701,P=0.021)were independent risk factors for OLM.TLRmax yielded the highest area under curve(AUC;AUC=0.794)with the threshold of 3.12,and the sensitivity,specificity,accuracy,positive predictive value and negative predictive value for predicting OLM were 92.0%(23/25),63.3%(100/158),67.2%(123/183),28.4%(23/81)and 98.0%(100/102),respectively.Conclusions TLRmax of tumor is the independent risk factor for OLM in NSCLC patients.TLRmax can sensitively predict OLM preoperatively in patients with NSCLC.
作者 史云梅 牛荣 王跃涛 邵晓梁 张飞飞 邵小南 王建锋 王小松 刘保 俞雯吉 Shi Yunmei;Niu Rong;Wang Yuetao;Shao Xiaoliang;Zhang Feifei;Shao Xiaonan;Wang Jianfeng;Wang Xiaosong;Liu Bao;Yu Wenji(Department of Nuclear Medicine,the Third Affiliated Hospital of Soochow University,the First People′s Hospital of Changzhou,Changzhou Key Laboratory of Molecular Imaging,Changzhou 213003,China)
出处 《中华核医学与分子影像杂志》 CAS CSCD 北大核心 2021年第6期327-333,共7页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 常州高技术研究重点实验室项目 (CM20193010)。
关键词 非小细胞肺 肿瘤转移 淋巴结 正电子发射断层显像术 体层摄影术 X线计算机 脱氧葡萄糖 预测 Carcinoma,non-small-cell lung Neoplasm metastasis Lymph nodes Positron-emission tomography Tomography,X-ray computed Deoxyglucose Forecasting
  • 相关文献

参考文献4

二级参考文献32

共引文献3576

同被引文献84

引证文献17

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部